Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: from JT's note

Good point, and I think you are right.  It does seem a bit extreme to state this unless it is significant in terms of dollars.  And they're taking the appropriate "high road" in citing the April release of financials (where "actuals" will become known in the aggregate).

This opens the door to my other recent "post gripe", that having to do with the expectation of silense, re: dollar income", until mid April.

Am I alone with the thought that we may get some forward-looking guidance before that time?  Like maybe a year end "state of the company" letter from JT?  Or perhaps accompanying the Jan 15 10Q?  I'm talking a statement of aggregate funds received to date, and maybe even expected further proceeds in the FY.  Is such a thing impossible?

Comments/opinions are solicited....

SGE

Share
New Message
Please login to post a reply